BlackRock Japan’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-90,983
| Closed | -$6.17M | – | 1312 |
|
2016
Q3 | $6.17M | Buy |
90,983
+1,229
| +1% | +$83.3K | 0.02% | 618 |
|
2016
Q2 | $4.98M | Buy |
89,754
+181
| +0.2% | +$10K | 0.02% | 637 |
|
2016
Q1 | $5.62M | Sell |
89,573
-346
| -0.4% | -$21.7K | 0.02% | 613 |
|
2015
Q4 | $8.47M | Sell |
89,919
-47
| -0.1% | -$4.43K | 0.03% | 548 |
|
2015
Q3 | $7.23M | Sell |
89,966
-3,760
| -4% | -$302K | 0.03% | 566 |
|
2015
Q2 | $11.2M | Buy |
+93,726
| New | +$11.2M | 0.04% | 463 |
|
2014
Q3 | – | Sell |
-1,070
| Closed | -$68K | – | 1249 |
|
2014
Q2 | $68K | Sell |
1,070
-1,240
| -54% | -$78.8K | ﹤0.01% | 997 |
|
2014
Q1 | $155K | Buy |
+2,310
| New | +$155K | ﹤0.01% | 989 |
|